Abstract
In cord blood (CB) transplantation, virtual 6/6 HLA matches, whereby the donor–recipient mismatch is identical to the CB noninherited maternal Ag (NIMA), have similar outcomes to inherited 6/6 matches. In the UK-British Bone Marrow Registry (BBMR), 4707 of the total 21 020 CB donors have the NIMA defined. Retrospective searches of these donors, for 1–3 NIMA matches, identified a virtual 6/6 match for 31.4% of 274 European Caucasoid (EC) and 25.4% of 67 other ethnicity (OE) patients. Patients weighing ⩽50 kg were also evaluated for a single graft with adequate cell dose. In 125 EC patients, 6/6 HLA matches were identified for 24.0% and virtual 6/6 matches were identified for a further 21.6%. The remaining EC patients had a 5/6 (30.4%) or a 4/6 (22.4%) match. In OE patients, 6/6 HLA matches were identified for 9.3% and virtual 6/6 matches were identified for a further 18.7%. The remaining OE patients had a 5/6 (30.2%) or a 4/6 (37.2%) match. Searches were also performed using the 26 735 Bone Marrow Donors Worldwide CB with defined NIMA and yielded comparable increases. Considering NIMA as permissible mismatches in donor selection therefore increased the availability of a 6/6 match in this cohort.
Similar content being viewed by others
References
Barker JN, Scaradavou A, Stevens CE . Combined effect of total nucleated cell dose and HLA match on transplantation outcome in 1061 cord blood recipients with hematologic malignancies. Blood 2010; 115: 1843–1849.
Eapen M, Klein JP, Ruggeri A, Spellman S, Lee SJ, Anasetti C et al. Impact of allele-level HLA matching on outcomes after myeloablative single unit umbilical cord blood transplantation for hematologic malignancy. Blood 2014; 123: 133–140.
Gragert L, Eapen M, Williams E, Freeman J, Spellman S, Baitty R et al. HLA match likelihoods for hematopoietic stem-cell grafts in the U.S. registry. N Engl J Med 2014; 371: 339–348.
Dutta P, Molitor-Dart M, Bobadilla JL, Roenneburg DA, Yan Z, Torrealba JR et al. Microchimerism is strongly correlated with tolerance to noninherited maternal antigens in mice. Blood 2009; 114: 3578–3587.
Mold JE, Michaëlsson J, Burt TD, Muench MO, Beckerman KP, Busch MP et al. Maternal alloantigens promote the development of tolerogenic fetal regulatory T cells in utero. Science 2008; 322: 1562–1565.
Mommaas B, Stegehuis-Kamp JA, van Halteren AG, Kester M, Enczmann J, Wernet P et al. Cord blood comprises antigen-experienced T cells specific for maternal minor histocompatibility antigen HA-1. Blood 2005; 105: 1823–1827.
van Rood JJ, Stevens CE, Smits J, Carrier C, Carpenter C, Scaradavou A . Reexposure of cord blood to noninherited maternal HLA antigens improves transplant outcome in hematological malignancies. Proc Natl Acad Sci USA 2009; 106: 19952–19957.
Rocha V, Spellman S, Zhang MJ, Ruggeri A, Purtill D, Brady C et al. Effect of HLA-matching recipients to donor noninherited maternal antigens on outcomes after mismatched umbilical cord blood transplantation for hematologic malignancy. Biol Blood Marrow Transplant 2012; 18: 1890–1896.
Burlingham WJ, Grailer AP, Heisey DM, Claas FH, Norman D, Mohanakumar T et al. The effect of tolerance to noninherited maternal HLA antigens on the survival of renal transplants from sibling donors. N Engl J Med 1998; 339: 1657–1664.
Wang Y, Chang YJ, Xu LP, Liu KY, Liu DH, Zhang XH et al. Who is the best donor for a related HLA haplotype-mismatched transplant? Blood 2014; 124: 843–850.
van Rood JJ, Loberiza FR, Zhang MJ, Oudshoorn M, Claas F, Cairo MS et al. Effect of tolerance to noninherited maternal antigens on the occurrence of graft-versus-host disease after bone marrow transplantation from a parent or an HLA-haploidentical sibling. Blood 2002; 99: 1572–1577.
Van der Zanden HG, Van Rood JJ, Oudshoorn M, Bakker JN, Melis A, Brand A et al. Noninherited maternal antigens identify acceptable HLA mismatches: benefit to patients and cost-effectiveness for cord blood banks. Biol Blood Marrow Transplant 2014; 20: 1791–1795.
Rocha V, Gluckman E . Improving outcomes of cord blood transplantation: HLA matching, cell dose and. Br J Haematol 2009; 147: 262–274.
Eapen M, Klein JP, Sanz GF, Spellman S, Ruggeri A, Anasetti C et al. Effect of donor-recipient HLA matching at HLA A, B, C, and DRB1 on outcomes after umbilical-cord blood transplantation for leukaemia and myelodysplastic syndrome: a retrospective analysis. Lancet Oncol 2011; 12: 1214–1221.
Acknowledgements
We thank all mothers for donating their CB to the NHS-Cord Blood Bank; Professor J van Rood for providing expertise and advice for the manuscript; BMDW for developing the NIMA Match Program; the Histocompatibility and Immunogenetics Laboratory at NHSBT Colindale for performing the HLA typing of maternal samples and A Niewiarowska for helpful discussions on the presentation of results. This work was funded by the British Bone Marrow Donor Appeal, administered through an NHSBT Trust Fund.
Author contributions
LP, CB and CVN contributed to the conception and design of the study; LP performed the research, interpreted the data and drafted the manuscript; CB and CVN supervised the study and reviewed the manuscript. AM developed and validated the BMDW NIMA Match Program. GP manages the banking and release of NHS-CBB CBUs and LY administers and provides the CBU donor files for submission to BMDW. All authors read and approved the final manuscript.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies this paper on Bone Marrow Transplantation website
Supplementary information
Rights and permissions
About this article
Cite this article
Powley, L., Brown, C., Melis, A. et al. Consideration of noninherited maternal Ags as permissible HLA mismatches in cord blood donor selection. Bone Marrow Transplant 51, 675–679 (2016). https://doi.org/10.1038/bmt.2015.344
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/bmt.2015.344
- Springer Nature Limited